FDA
-
-
-
-
-
-
-
BioVie to discuss Phase 2 Long Covid trial results in conference call
-
-
-
-
-
-
-
Citizens Reiterates Market Outperform Rating on Exelixis (EXEL)
-
-
-
-
-
-
-
ISS backs all six Anavex director nominees ahead of annual meeting
-
-
-
-
-
-
-
TuHURA Biosciences gets FDA clearance to trial AML antibody
-
-
-
-
-
-
-
Definium's LSD-based pill meets Phase 3 goals in anxiety trial
-
-
-
-
-
-
-
Scholar Rock (SRRK) PT Raised to $72 at Raymond James
-
-
-
-
-
-
-
Enhertu shows 14.3-month PFS in first-line lung cancer trial
-
330,909 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

